Re: Zenith poster from AACR EORTC meeting and Annual General/Special meeting date
|
3
|
Resverlogix Corp.
|
Nov 13, 2015 09:49AM
|
Re: BetonMace Phase 111 Trial opinions...
|
3
|
Resverlogix Corp.
|
Jun 05, 2015 09:05AM
|
Middle Eastern $
|
3
|
Resverlogix Corp.
|
Sep 01, 2023 12:06PM
|
Re: Lilly to Discontinue Development of Evacetrapib
|
3
|
Resverlogix Corp.
|
Nov 17, 2015 04:31PM
|
Re: NEW NR
|
3
|
Resverlogix Corp.
|
Aug 04, 2015 10:46AM
|
Re: major disconnect in Share price/value to other biotech is same space
|
3
|
Resverlogix Corp.
|
Aug 20, 2015 02:13PM
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 04:47PM
|
Re: Almost 1.25 years now
|
3
|
Zenith Epigenetics
|
May 31, 2018 04:05PM
|
Re: Enthusiasm? NOT!
|
3
|
Zenith Epigenetics
|
Oct 30, 2021 06:00PM
|
Re: Zenith poster from AACR EORTC meeting and Annual General/Special meeting date
|
3
|
Resverlogix Corp.
|
Nov 14, 2015 01:05PM
|
Re: The Longer It Lasts, The Better It Is???
|
3
|
Resverlogix Corp.
|
Dec 22, 2015 08:25AM
|
Re: Zenith prezzy
|
3
|
Zenith Epigenetics
|
Jun 24, 2017 11:40AM
|
Trial Status
|
3
|
Resverlogix Corp.
|
Jul 20, 2021 11:09AM
|
Value
|
3
|
Resverlogix Corp.
|
Jun 29, 2017 04:29PM
|
Re: Dropping on the opening on the "pinks"
|
3
|
Resverlogix Corp.
|
Jul 29, 2015 12:39PM
|
Re: Debenture questions.
|
3
|
Resverlogix Corp.
|
Feb 17, 2022 12:57PM
|
Re: AGM June 21
|
3
|
Resverlogix Corp.
|
May 13, 2022 06:20PM
|
Violation update
|
3
|
Resverlogix Corp.
|
Jun 24, 2016 08:07AM
|
What if a deal is in the works?
|
3
|
Resverlogix Corp.
|
Sep 17, 2019 02:37PM
|
No word on...
|
3
|
Resverlogix Corp.
|
Jul 12, 2021 10:22AM
|